People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aclaimant, Inc. | — | Other Technology | Series A | $21.9M | $25.3M | 2021 |
| Khiron Life Sciences Corp. | — | Other | Series A | $10.8M | $8.1M | 2021 |
| Spindle Research Llc | — | Other Technology | Pre-Seed | $490K | $20.8M | 2009 |
Joel Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joel Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| C. Thomas Ball | 1 | 12 |
| David Gold | 1 | 7 |
| Adrian Fortino | 1 | 5 |
| Swapan Kakumanu | 1 | 4 |
| Laura Brady | 1 | 3 |
| Michael Schultz | 1 | 2 |
| TEJINDER VIRK | 1 | 2 |
| Alvaro Torres | 1 | 1 |
| Juan Carlos Echeverry | 1 | 1 |
| Nicholas Diamand | 1 | 1 |
| David Wald | 1 | 1 |
| Kathleen Burns | 1 | 1 |
| Deborah Rosati | 1 | 1 |
| Vicente Fox | 1 | 1 |
| Alvaro Yanez | 1 | 1 |
| Chris Naprawa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.